Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery

Trends in Pharmacological Sciences
J M StadelD J Bergsma

Abstract

Access to DNA databases has introduced an exciting new dimension to the way biomedical research is conducted. 'Genomic research' offers tremendous opportunity for accelerating the identification of the cause of disease at the molecular level and thereby foster the discovery of more selective medicines to improve human health and longevity. The current challenge is to close the gap rapidly between gene identification and clinical development of efficacious therapeutics. In the present review, Jeffrey Stadel, Shelagh Wilson and Derk Bergsma outline the rationale and describe strategies for converting one large class of novel genes, orphan G protein-coupled receptors (GPCRs), into therapeutic targets. Historically, the superfamily of GPCRs has proven to be among the most successful drug targets and consequently these newly isolated orphan receptors have great potential for pioneer drug discovery.

References

Mar 31, 1992·Biochemical and Biophysical Research Communications·D J BergsmaN Aiyar
Jan 1, 1991·Annual Review of Biochemistry·H G DohlmanR J Lefkowitz
Apr 1, 1995·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·D M BakerG S Makin
Jun 23, 1995·The Journal of Biological Chemistry·S Offermanns, M I Simon
Jan 27, 1995·Cell·D E Clapham
Jan 1, 1994·Annual Review of Biochemistry·C D StraderR A Dixon
Apr 15, 1993·Nature
Apr 22, 1993·Nature·G F SchertlerR Henderson
Feb 23, 1996·Science·W Roush
May 10, 1996·The Journal of Biological Chemistry·N AiyarY Li
Aug 23, 1996·The Journal of Biological Chemistry·R S AmesC Kumar
Jan 1, 1996·Annual Review of Pharmacology and Toxicology·R K SunaharaA G Gilman
Jul 1, 1996·Trends in Pharmacological Sciences·G MilliganS Rees
Nov 1, 1996·Trends in Biotechnology·C G Tate, R Grisshammer

❮ Previous
Next ❯

Citations

Jun 2, 2000·Biochemical and Biophysical Research Communications·M MatsumotoK Furuichi
Jul 25, 2000·Biochemical and Biophysical Research Communications·R Staudinger, J C Bandres
Oct 12, 2000·Biochemical and Biophysical Research Communications·Y KawasawaT Shimizu
Feb 5, 2002·General and Comparative Endocrinology·Yoshimi Yasuda-Kamatani, Akikazu Yasuda
Jun 19, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Kasra Shakeri-NejadJasper Dingemanse
Nov 25, 2004·Seminars in Cell & Developmental Biology·Darren R Flower, Teresa K Attwood
Apr 6, 2004·Trends in Pharmacological Sciences·Stephen A DouglasDouglas G Johns
May 2, 2001·Biochemical Pharmacology·J Sondek, D P Siderovski
Mar 10, 2001·Trends in Pharmacological Sciences·A D HowardA A Patchett
Apr 3, 2001·Trends in Pharmacological Sciences·T K Attwood
Jun 30, 2001·Trends in Pharmacological Sciences·M J Marinissen, J S Gutkind
Apr 22, 1999·Trends in Pharmacological Sciences·G Milligan, S Rees
Aug 27, 1999·Trends in Pharmacological Sciences·A MarcheseB F O'Dowd
Feb 24, 2000·Biochimica Et Biophysica Acta·D K LeeA Marchese
Nov 5, 1999·Biochimica Et Biophysica Acta·D R Flower
Nov 20, 1998·Current Opinion in Biotechnology·H Reiländer, H M Weiss
Feb 19, 2000·Current Opinion in Biotechnology·K G Fleming
Jan 12, 1999·British Journal of Pharmacology·S WilsonJ M Stadel
Dec 3, 1999·European Journal of Biochemistry·J H LeeW Lee
Jan 5, 2000·Journal of Neurochemistry·D K LeeB F O'Dowd
Apr 20, 2004·Assay and Drug Development Technologies·Elaine J AdieStephen Game
Jul 21, 2001·EMBO Reports·M VerseleJ M Thevelein
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Alan WiseStephen Rees
May 17, 2003·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Jean-Claude Meunier
Dec 31, 2002·Journal of Receptor and Signal Transduction Research·A GagneS D Hurt
Feb 22, 2011·Bioorganic & Medicinal Chemistry Letters·Malken BayrakdarianMirosław J Tomaszewski
Feb 26, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yoshiya YamamotoSetsuo Hirohashi
Jul 23, 2002·Journal of Chemical Information and Computer Sciences·Ansgar SchuffenhauerEdgar Jacoby
Jul 30, 2003·Expert Opinion on Therapeutic Targets·Guillaume Hervieu
Aug 11, 2001·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·T Oda, S Matsumoto
Oct 30, 1998·Biochemical and Biophysical Research Communications·K TatemotoM Fujino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.